Geralyn LaVecchia

Geralyn LaVecchia


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2023 in Life
Verified
Journal Article
Open access
PDF file
TFTheresa Frantzen
Theresa Frantzen
SBSara Barsky
Sara Barsky
GLGeralyn LaVecchia
Geralyn LaVecchia
MMmichelle marowitz
michelle marowitz
JWJanice Wang
Janice Wang
The course of cystic fibrosis (CF) as a nutritional illness is diverging since the introduction of highly effective modulator therapy, leading to more heterogeneous phenotypes of the disease despite CF genetic mutations that portend worse prognosis. This may become more evident as we follow the pediatric CF population into adulthood as some highly effective modulator therapies (HEMT) are approved for those as young as 1 year old. This review will outline the current research and knowledge available in the evolving nutritional health of people with CF as it relates to the impact of HEMT on anthropometrics, body composition, and energy expenditure, exocrine and endocrine pancreatic insufficiencies (the latter resulting in CF-related diabetes), vitamin and mineral deficiencies, and nutritional health in CF as it relates to pregnancy and lung transplantation.

21 February 2022 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
JSJoseph L. Simonson
Joseph L. Simonson
CEChristine Esposito
Christine Esposito
TFTheresa Frantzen
Theresa Frantzen
KHKatherine Henthorne
Katherine Henthorne
AEAileen Espinal
Aileen Espinal
JWJanice Wang
Janice Wang